Hims & Hers Health, Inc. HIMS
Price
Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)
Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.
Results from SEC filings
| Revenue | $2.3B | +59% | FY ending Dec 31, 2025 |
|---|---|---|---|
| Gross profit | $1.7B | +48% | FY ending Dec 31, 2025 |
| Operating income | $105.6M | +71% | FY ending Dec 31, 2025 |
| Net income | $128.4M | +2% | FY ending Dec 31, 2025 |
| Earnings per share | $0.51 | -4% | FY ending Dec 31, 2025 |
| Cash from operations | $300.0M | +19% | FY ending Dec 31, 2025 |
| Share buybacks | $90.0M | +8% | FY ending Dec 31, 2025 |
| Cash | $228.6M | +4% | FY ending Dec 31, 2025 |
| Shareholders' equity | $540.9M | +13% | FY ending Dec 31, 2025 |
Insider trades
Last 12 months: 1 open-market buy ($1.2M) and 45 sales ($19.3M) by officers, directors and big owners. These are exact: shares times the price each insider reported. Several sales by one person on one day are combined (average price).
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Soleil BoughtonChief Legal Officer | Soldpre-set plan | 3,461 | $29.06 | $101K | Oct 14, 2026 |
| Oluyemi OkupeChief Financial Officer | Soldpre-set plan | 2,000 | $29.70 | $59K | Oct 1, 2026 |
| Soleil BoughtonChief Legal Officer | Soldpre-set plan | 3,461 | $29.17 | $101K | Sep 30, 2026 |
| Oluyemi OkupeChief Financial Officer | Soldpre-set plan | 29,277 | $29.95 | $877K | Sep 22, 2026 |
| Oluyemi OkupeChief Financial Officer | Soldpre-set plan | 12,313 | $28.82 | $355K | Sep 17, 2026 |
| Soleil BoughtonChief Legal Officer | Soldpre-set plan | 6,236 | $27.86 | $174K | Sep 16, 2026 |
| Michael ChiChief Operating Officer | Soldpre-set plan | 14,027 | $28.39 | $398K | Sep 15, 2026 |
| Mohamed ElshenawyCTO | Soldpre-set plan | 7,954 | $28.39 | $226K | Sep 15, 2026 |
| Soleil BoughtonChief Legal Officer | Soldpre-set plan | 3,458 | $28.33 | $98K | Sep 2, 2026 |
| Soleil BoughtonChief Legal Officer | Soldpre-set plan | 25,111 | $27.55 | $692K | Aug 19, 2026 |
| Oluyemi OkupeChief Financial Officer | Soldpre-set plan | 4,938 | $29.99 | $148K | Aug 19, 2026 |
| Deborah M. AutorChief Policy Officer, Director | Soldpre-set plan | 16,773 | $27.85 | $467K | Aug 18, 2026 |
| Oluyemi OkupeChief Financial Officer | Soldpre-set plan | 9,388 | $27.89 | $262K | Aug 17, 2026 |
| Oluyemi OkupeChief Financial Officer | Soldpre-set plan | 7,163 | $31.99 | $229K | Jul 17, 2026 |
| Oluyemi OkupeChief Financial Officer | Soldpre-set plan | 7,163 | $36.49 | $261K | Jul 6, 2026 |
| Oluyemi OkupeChief Financial Officer | Soldpre-set plan | 18,197 | $34.03 | $619K | Jun 22, 2026 |
| Oluyemi OkupeChief Financial Officer | Soldpre-set plan | 55,383 | $35.09 | $1.9M | Jun 18, 2026 |
| Patrick Harrison CarrollChief Medical Officer | Sold | 23,726 | $35.00 | $830K | Jun 18, 2026 |
| Mohamed ElshenawyCTO | Soldpre-set plan | 30,040 | $31.50 | $946K | Jun 17, 2026 |
| Michael ChiChief Operating Officer | Soldpre-set plan | 14,027 | $31.50 | $442K | Jun 17, 2026 |
| Irene BecklundPAO | Soldpre-set plan | 4,490 | $31.50 | $141K | Jun 17, 2026 |
| Irene BecklundPAO | Soldpre-set plan | 7,573 | $30.25 | $229K | Jun 16, 2026 |
| David B WellsDirector | Bought | 48,400 | $24.23 | $1.2M | May 26, 2026 |
| Oluyemi OkupeChief Financial Officer | Soldpre-set plan | 7,950 | $23.64 | $188K | May 18, 2026 |
| Oluyemi OkupeChief Financial Officer | Soldpre-set plan | 19,645 | $29.96 | $589K | Apr 20, 2026 |
| Soleil BoughtonChief Legal Officer | Soldpre-set plan | 9,463 | $30.00 | $284K | Apr 20, 2026 |
| Oluyemi OkupeChief Financial Officer | Soldpre-set plan | 18,005 | $27.83 | $501K | Apr 17, 2026 |
| Oluyemi OkupeChief Financial Officer | Soldpre-set plan | 36,922 | $25.90 | $956K | Apr 16, 2026 |
| Oluyemi OkupeChief Financial Officer | Soldpre-set plan | 3,975 | $19.98 | $79K | Apr 6, 2026 |
| Oluyemi OkupeChief Financial Officer | Soldpre-set plan | 9,217 | $23.77 | $219K | Mar 20, 2026 |
| Michael ChiChief Operating Officer | Soldpre-set plan | 97,289 | $24.69 | $2.4M | Mar 17, 2026 |
| Irene BecklundPAO | Soldpre-set plan | 5,529 | $24.69 | $137K | Mar 17, 2026 |
| Soleil BoughtonChief Legal Officer | Soldpre-set plan | 4,812 | $24.69 | $119K | Mar 17, 2026 |
| Soleil BoughtonChief Legal Officer | Soldpre-set plan | 4,651 | $15.21 | $71K | Feb 27, 2026 |
| Oluyemi OkupeChief Financial Officer | Soldpre-set plan | 5,262 | $26.44 | $139K | Feb 3, 2026 |
| Oluyemi OkupeChief Financial Officer | Soldpre-set plan | 9,067 | $30.34 | $275K | Jan 20, 2026 |
| Oluyemi OkupeChief Financial Officer | Soldpre-set plan | 9,070 | $33.79 | $306K | Jan 5, 2026 |
| Oluyemi OkupeChief Financial Officer | Soldpre-set plan | 23,090 | $35.72 | $825K | Dec 22, 2025 |
| Michael ChiChief Operating Officer | Soldpre-set plan | 13,750 | $36.71 | $505K | Dec 17, 2025 |
| Patrick Harrison CarrollChief Medical Officer, Director | Soldpre-set plan | 10,021 | $36.71 | $368K | Dec 17, 2025 |
Other insider moves (108): pay awards, option exercises, tax withholding, gifts
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Oluyemi OkupeChief Financial Officer | Option exercisepre-set plan | 14,000 | $5.01 | $70K | Sep 22, 2026 |
| Andrew DudumChief Executive Officer, Director, 10% owner | Other | 977,566 | – | – | Aug 27, 2026 |
| Andrew DudumChief Executive Officer, Director, 10% owner | Gift | 463,289 | – | – | Aug 25, 2026 |
| Oluyemi OkupeChief Financial Officer | Option exercisepre-set plan | 4,938 | $5.01 | $25K | Aug 19, 2026 |
| Oluyemi OkupeChief Financial Officer | Option exercisepre-set plan | 9,388 | $5.01 | $47K | Aug 17, 2026 |
| Mohamed ElshenawyCTO | Tax withholding | 95,798 | $28.15 | $2.7M | Aug 14, 2026 |
| Andrew DudumChief Executive Officer, Director, 10% owner | Tax withholding | 78,859 | $28.15 | $2.2M | Aug 14, 2026 |
| Michael ChiChief Operating Officer | Tax withholding | 47,702 | $28.15 | $1.3M | Aug 14, 2026 |
| Oluyemi OkupeChief Financial Officer | Tax withholdingpre-set plan | 36,437 | $28.15 | $1.0M | Aug 14, 2026 |
| Soleil BoughtonChief Legal Officer | Tax withholding | 21,500 | $28.15 | $605K | Aug 14, 2026 |
| Deborah M. AutorChief Policy Officer, Director | Tax withholding | 16,147 | $28.15 | $455K | Aug 14, 2026 |
| Patrick Harrison CarrollChief Medical Officer | Tax withholding | 10,201 | $28.15 | $287K | Aug 14, 2026 |
| Irene BecklundPAO | Tax withholding | 6,490 | $28.15 | $183K | Aug 14, 2026 |
| Soleil BoughtonChief Legal Officer | Option exercise | 42,261 | – | – | Aug 14, 2026 |
| Kare SchultzDirector | Option exercise | 6,623 | – | – | Aug 14, 2026 |
| Patrick Harrison CarrollChief Medical Officer | Option exercise2 fills | 26,187 | – | – | Aug 14, 2026 |
| Andrew DudumChief Executive Officer, Director, 10% owner | Option exercise | 154,993 | – | – | Aug 14, 2026 |
| Michael ChiChief Operating Officer | Option exercise | 86,265 | – | – | Aug 14, 2026 |
| Oluyemi OkupeChief Financial Officer | Option exercisepre-set plan | 71,616 | – | – | Aug 14, 2026 |
| Deborah M. AutorChief Policy Officer, Director | Option exercise | 32,920 | – | – | Aug 14, 2026 |
| David B WellsDirector | Option exercise | 778 | – | – | Aug 14, 2026 |
| Mohamed ElshenawyCTO | Option exercise | 188,285 | – | – | Aug 14, 2026 |
| Irene BecklundPAO | Option exercise | 13,685 | – | – | Aug 14, 2026 |
| Christopher D PayneDirector | Option exercise | 545 | – | – | Aug 14, 2026 |
| Oluyemi OkupeChief Financial Officer | Option exercisepre-set plan | 7,163 | $5.01 | $36K | Jul 17, 2026 |
| Oluyemi OkupeChief Financial Officer | Option exercisepre-set plan | 7,163 | $5.01 | $36K | Jul 6, 2026 |
| Oluyemi OkupeChief Financial Officer | Option exercisepre-set plan | 6,376 | $5.01 | $32K | Jun 22, 2026 |
| Mohamed ElshenawyCTO | Tax withholdingpre-set plan | 151,534 | $30.17 | $4.6M | Jun 15, 2026 |
| Andrew DudumChief Executive Officer, Director, 10% owner | Tax withholding | 85,632 | $30.17 | $2.6M | Jun 15, 2026 |
| Michael ChiChief Operating Officer | Tax withholdingpre-set plan | 47,699 | $30.17 | $1.4M | Jun 15, 2026 |
| Oluyemi OkupeChief Financial Officer | Tax withholding | 39,541 | $30.17 | $1.2M | Jun 15, 2026 |
| Soleil BoughtonChief Legal Officer | Tax withholding | 23,315 | $30.17 | $703K | Jun 15, 2026 |
| Deborah M. AutorChief Policy Officer, Director | Tax withholding | 15,396 | $30.17 | $464K | Jun 15, 2026 |
| Patrick Harrison CarrollChief Medical Officer | Tax withholding | 8,310 | $30.17 | $251K | Jun 15, 2026 |
| Irene BecklundPAO | Tax withholdingpre-set plan | 5,870 | $30.17 | $177K | Jun 15, 2026 |
| Patrick Harrison CarrollChief Medical Officer | Option exercise2 fills | 26,361 | – | – | Jun 15, 2026 |
| Oluyemi OkupeChief Financial Officer | Option exercise | 71,616 | – | – | Jun 15, 2026 |
| Deborah M. AutorChief Policy Officer, Director | Option exercise | 32,919 | – | – | Jun 15, 2026 |
| Michael ChiChief Operating Officer | Option exercisepre-set plan | 86,264 | – | – | Jun 15, 2026 |
| Irene BecklundPAO | Option exercisepre-set plan | 15,971 | – | – | Jun 15, 2026 |
| Soleil BoughtonChief Legal Officer | Option exercise | 42,261 | – | – | Jun 15, 2026 |
| Andrew DudumChief Executive Officer, Director, 10% owner | Option exercise | 154,991 | – | – | Jun 15, 2026 |
| Mohamed ElshenawyCTO | Option exercisepre-set plan | 282,597 | – | – | Jun 15, 2026 |
| David B WellsDirector | Option exercise | 957 | – | – | Jun 15, 2026 |
| Christopher D PayneDirector | Option exercise2 fills | 10,687 | – | – | Jun 15, 2026 |
| Anja ManuelDirector | Option exercise | 10,040 | – | – | Jun 15, 2026 |
| David B WellsDirector | Option exercise | 3,656 | – | – | Jun 11, 2026 |
| Kare SchultzDirector | Option exercise | 3,656 | – | – | Jun 11, 2026 |
| Garcia Andrea G PerezDirector | Option exercise | 3,656 | – | – | Jun 11, 2026 |
| Patrick Harrison CarrollChief Medical Officer | Option exercise | 3,656 | – | – | Jun 11, 2026 |
| Deborah M. AutorChief Policy Officer, Director | Option exercise | 3,656 | – | – | Jun 11, 2026 |
| Christopher D PayneDirector | Option exercise | 3,656 | – | – | Jun 11, 2026 |
| Christiane PendarvisDirector | Option exercise | 3,656 | – | – | Jun 11, 2026 |
| Anja ManuelDirector | Option exercise | 3,656 | – | – | Jun 11, 2026 |
| Delos M. CosgroveDirector | Option exercise | 3,656 | – | – | Jun 11, 2026 |
| Oluyemi OkupeChief Financial Officer | Option exercisepre-set plan | 7,950 | $5.01 | $40K | May 18, 2026 |
| Oluyemi OkupeChief Financial Officer | Option exercisepre-set plan2 fills | 12,553 | $8.65 avg | $109K | Apr 20, 2026 |
| Oluyemi OkupeChief Financial Officer | Option exercisepre-set plan | 6,184 | $5.01 | $31K | Apr 17, 2026 |
| Andrew DudumChief Executive Officer, Director, 10% owner | Gift | 422,933 | – | – | Apr 9, 2026 |
| Andrew DudumChief Executive Officer, Director, 10% owner | Gift | 422,933 | – | – | Apr 9, 2026 |
Trades by members of Congress
1 member reported 1 buy and 0 sales since Aug 4, 2025. Amounts are legal ranges, not exact figures.
| Member | Trade | Amount | Traded | Reported | Owner |
|---|---|---|---|---|---|
| Lisa C. McClain R | Bought | $1,001–$15K | Aug 4, 2025 | Sep 12, 2025 | Spouse |
Latest SEC filings
- Insider plans to sell 144 · Oct 28, 2026
- Insider plans to sell 144 · Oct 14, 2026
- News filing: Executive or board change 8-K · Oct 7, 2026
- Insider plans to sell 144 · Oct 1, 2026
- Insider plans to sell 144 · Sep 30, 2026
- Insider plans to sell 144 · Sep 22, 2026
- Insider plans to sell 144 · Sep 17, 2026
- Insider plans to sell 144 · Sep 16, 2026
- Insider plans to sell 144 · Sep 15, 2026
- Insider plans to sell 144 · Sep 15, 2026
- Insider plans to sell 144 · Sep 2, 2026
- Insider plans to sell 144 · Aug 19, 2026
- Insider plans to sell 144 · Aug 18, 2026
- Quarterly report 10-Q · Aug 10, 2026
- News filing: Quarterly results 8-K · Aug 10, 2026
- Insider plans to sell 144 · Jul 22, 2026
- News filing: Executive or board change 8-K · Jul 17, 2026
- Insider plans to sell 144 · Jul 6, 2026
- News filing: Signed a major agreement, Took on new debt 8-K · Jul 1, 2026
- Insider plans to sell 144 · Jun 18, 2026
- Insider plans to sell 144 · Jun 17, 2026
- Insider plans to sell 144 · Jun 17, 2026
- Insider plans to sell 144 · Jun 17, 2026
- Insider plans to sell 144 · Jun 16, 2026
- News filing: Shareholder vote results 8-K · Jun 15, 2026
About Hims & Hers Health, Inc.
Business description
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- Sector
- Industrial Applications and Services
- Headquarters
- San Francisco, CA
- Incorporated in
- DE
- Fiscal year ends
- December 31
- Exchange
- NYSE
- Filer size
- Large accelerated filer
- Formerly
- Oaktree Acquisition Corp.
- SEC company number (CIK)
- 1773751
Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.